• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Dermira anyone?























It’ll be a wipeout but a billion dollar check the box by ceo to demonstrate “proactive pursuit of outside business opportunities”. Probably will buy the ceo another year or two from the board. Besides, what’s a billion to Lilly?
 




We just acquired a pit wipe with a amateur team. This isn’t going to do much for us. It clearly shows wall street that we don’t have a fern pipeline. We are officially Pfizer, buying our pipeline.